Chimerix, Inc. is a biopharmaceutical company that develops medicines to improve the lives of patients with serious diseases. The company's current approved medication is TEMBEXA for the treatment of smallpox. Chimerix also has other clinical stage development programs in progress, including treatments for solid tumors, hematological malignancies, and acute myeloid leukemia.